Otilia Dalesio
- Oncology top 0.5%
- Lung Cancer Research Studies 15
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 10
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 18
- Prostate Cancer Treatment and Research 11
- Lung Cancer Diagnosis and Treatment 9
- Otorhinolaryngology top 1%
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Cancer Research top 2%
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Nico van ZandwijkWolter J. MooiJohannes L. PeterseMarc J. van de VijverSjoerd RodenhuisRoel NusseCornelis J.A. PuntFrans Erdkamp
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
Otilia Dalesio
103 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 4.4k
- Pulmonary and Respiratory Medicine 3.9k
- Otorhinolaryngology 346
- Hepatology 581
- Cancer Research 1.0k
Countries citing papers authored by Otilia Dalesio
This map shows the geographic impact of Otilia Dalesio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otilia Dalesio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otilia Dalesio more than expected).
Fields of papers citing papers by Otilia Dalesio
This network shows the impact of papers produced by Otilia Dalesio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otilia Dalesio. The network helps show where Otilia Dalesio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Otilia Dalesio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 31 | |
| 2 | 2011 | 79 | |
| 3 | 2009 | 11 | |
| 4 | 2007 | 5 | |
| 5 | 2007 | 17 | |
| 6 | 1998 | 182 | |
| 7 | 1997 | 5 | |
| 8 | 1997 | 7 | |
| 9 | 1997 | 16 | |
| 10 | ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY | 1995 | 2 |
| 11 | MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS | 1995 | 195 |
| 12 | 1994 | 15 | |
| 13 | 1994 | 49 | |
| 14 | 1993 | 12 | |
| 15 | 1993 | 108 | |
| 16 | 1990 | 56 | |
| 17 | 1988 | 8 | |
| 18 | Autologous bone marrow transplantation and solid tumors | 1984 | 4 |
| 19 | 1984 | 71 | |
| 20 | 1983 | 128 |
About Otilia Dalesio
Otilia Dalesio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 104 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (15 papers), Colorectal Cancer Treatments and Studies (12 papers), Prostate Cancer Treatment and Research (11 papers), Cancer therapeutics and mechanisms (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Treatment and Pharmacology (10 papers) and Lung Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Oncology (4.4k citations), Pulmonary and Respiratory Medicine (3.9k citations) and Otorhinolaryngology (346 citations). Otilia Dalesio has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Nico van Zandwijk, Wolter J. Mooi, Johannes L. Peterse, Marc J. van de Vijver, Sjoerd Rodenhuis, Roel Nusse, Cornelis J.A. Punt, Frans Erdkamp, Miriam Koopman and Linda Mol. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Lung Cancer and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.